Lauterslager Tosca G M, Hilgers Luuk A T
ID-Lelystad B.V., PO Box 65, NL-8200 AB Lelystad, The Netherlands.
Immunol Lett. 2002 Dec 3;84(3):185-90. doi: 10.1016/s0165-2478(02)00184-0.
To evaluate whether vaccine administration via intragastric gavage is indicative for the outcome of edible vaccines, mice were orally immunised with ovalbumin (OVA) mixed with or without Vibrio cholerae toxin (CT) in various compositions via various routes: (1) OVA dissolved in saline and intragastrically (IG) administered ('IG'); (2) OVA mixed with food extract and administered IG ('food IG'); (3) food chow absorbed with OVA dissolved in saline and fed to the animals ('food'); and (4) OVA dissolved in saline and administered via drinking bottles ('drinking'). When given to naive mice, 'IG' and 'food IG' but not 'food' or 'drinking' induced anti-OVA IgG1 responses in serum, but oral boost immunisations were necessary. Serum IgA was not induced. Oral boosting of subcutaneously (SC) primed mice enhanced the IgG1 and IgA response in serum regardless of the route of immunisation or the vaccine composition. CT did not dramatically enhance the immune response. All immunisation routes except 'drinking' induced antigen-specific IgA antibody secreting cells (ASC) in the lamina propria of naive mice. But antigen-specific antibody responses in faeces were not observed. We concluded that oral (i.e. IG) administration is distinct from oral intake. The composition of the vaccine (food or saline) did not influence oral administration. We thus suggested that the route of administration greatly influenced the outcome of oral immunisation. Although oral administration is a well-accepted route to test the potentials of oral vaccines, our study demonstrated that it is merely indicative for the effectiveness of edible vaccines. Studies on the feasibility of edible vaccines should thus be performed by eating the vaccine.
为了评估通过灌胃给予疫苗是否可预示可食用疫苗的效果,将小鼠通过不同途径用含有或不含霍乱毒素(CT)的不同组成的卵清蛋白(OVA)进行口服免疫:(1)将OVA溶解于盐水中并经胃内(IG)给予(“IG”);(2)将OVA与食物提取物混合并经胃内给予(“食物IG”);(3)用溶解于盐水中的OVA吸收食物并喂给动物(“食物”);以及(4)将OVA溶解于盐水中并通过饮水瓶给予(“饮水”)。当给予未免疫的小鼠时,“IG”和“食物IG”而非“食物”或“饮水”诱导血清中抗OVA IgG1反应,但需要口服加强免疫。未诱导血清IgA。对皮下(SC)初免的小鼠进行口服加强免疫可增强血清中的IgG1和IgA反应,而与免疫途径或疫苗组成无关。CT并未显著增强免疫反应。除“饮水”外的所有免疫途径均在未免疫小鼠的固有层中诱导抗原特异性IgA抗体分泌细胞(ASC)。但未观察到粪便中的抗原特异性抗体反应。我们得出结论,口服(即IG)给药与经口摄入不同。疫苗的组成(食物或盐水)不影响口服给药。因此,我们认为给药途径极大地影响口服免疫的效果。尽管口服给药是测试口服疫苗潜力的一种广泛接受的途径,但我们的研究表明,它仅可预示可食用疫苗的有效性。因此,关于可食用疫苗可行性的研究应通过食用疫苗来进行。